Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

1articles mentioning institutions

4institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: FEDRA ×

FEDRA

This institution is selected. Its supporting articles are shown below.

Articles mentioning FEDRA

1 articles · page 1 of 1

5PSQ-093 Myocarditis-myositis-myasthenia gravis overlap syndrome: an emerging severe adverse reaction among immune checkpoint inhibitors. Analysis of reports in the Spanish adverse reactions database (FEDRA)

ejhpharm · abstract · 2026-03-18 · 4 matching annotations

91.0%

FEDRA Pharmacovigilance Centre pembrolizumab nivolumab ipilimumab myasthenia gravis myositis-myocarditis-myasthenia gravis

…ata retrieved from Individual Case Safety Reports identified in FEDRA since 2011, marketing year of ipilimumab, of suspected ADR repo…